Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

1976 • 5,620 citations

Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

1991 • 1,386 citations

An Improved Approximate Formula for Calculating Sample Sizes for Comparing Two Binomial Distributions

1978 • 423 citations

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1991 • 387 citations

High-dose cytosine arabinoside therapy for refractory leukemia

1983 • 372 citations

Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)

1987 • 266 citations

Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia

1985 • 259 citations

Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.

1992 • 248 citations

Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates

1969 • 234 citations

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

1993 • 229 citations

Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study

1990 • 228 citations

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1994 • 210 citations

Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies

1990 • 188 citations

Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study

1992 • 184 citations

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group

1992 • 183 citations

Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study

1992 • 141 citations

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

1990 • 110 citations

THE BERLIN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY STUDY, 1970-1976

1980 • 110 citations

Neurotoxicity Due to Central Nervous System Therapy for Childhood Leukemia

1989 • 109 citations

Therapy Results in Five ALL-BFM Studies Since 1970: Implications of Risk Factors for Prognosis

1987 • 104 citations

Second Malignant Neoplasms in Patients Treated for Childhood Leukemia: A Population‐based Cohort Study from the Nordic Countries

1991 • 97 citations

Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).

1973 • 89 citations

Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update)

1991 • 86 citations

Treatment Strategy for Different Risk Groups in Childhood Acute Lymphoblastic Leukemia: A Report From the BFM Study Group

1981 • 77 citations

Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.

1984 • 63 citations

High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia

1993 • 44 citations

Clinical Significance of Cytogenetic Studies in Childhood Acute Lymphoblastic Leukemia: Experience of the BFM Trials

1993 • 36 citations

Dutch Childhood Leukemia Study Group: Early Results of Study ALL VI (1984–1988)

1990 • 35 citations

Frequency and Clinical Significance of DNA Aneuploidy in Acute Leukemia

1986 • 34 citations

Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia

1992 • 30 citations

CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate

1990 • 28 citations

Prophylactic cranial irradiation increases the risk of testicular damage in adult males surviving all in childhood

1993 • 22 citations

Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia

1985 • 17 citations

High-dose cytosine arabinoside therapy for refractory leukemia

1983 • 14 citations

Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies

1991 • 14 citations

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group

1992 • 13 citations

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia in children: I. The Norwegian methotrexate study in acute lymphoblastic leukemia in childhood, august 1975‐December 1980

1986 • 10 citations

Deleted Work

1955 • 0 citations